Get started
Author

Antoine Ittel

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
2022 · Sylvain Garciaz, Anne-Sophie Alary, et al. · Cancers · 66
PDF
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53
2019 · Elise Chapiro, Elodie Pramil, et al. · Blood · 53
PDF
First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia
2013 · A. Ittel, E. Jeandidier, et al. · Haematologica · 36
PDF
A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm
2012 · C Gervais, L Dano, et al. · Leukemia · 36
Sumoylation Inhibits the Growth Suppressive Properties of Ikaros
2016 · Apostol Apostolov, Isma Litim-Mecheri, et al. · PLoS ONE · 21
PDF
Clinical and biological features of B‐cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities
2020 · Baptiste Gailllard, Pascale Cornillet‐Lefebvre, et al. · British Journal of Haematology · 15
PDF
Azacitidine–venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients
2023 · C. Petit, C. Saillard, et al. · European Journal Of Haematology · 14
Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia
2024 · Guillaume Berton, Bochra Sedaki, et al. · Leukemia Research · 8
TheCADM1tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
2021 · Marina Lafage-Pochitaloff, Bastien Gerby, et al. · Blood Advances · 8
PDF
Large deletions of the 5′ region of IKZF 1 lead to haploinsufficiency in B‐cell precursor acute lymphoblastic leukaemia
2019 · Guillaume Morel, Marie‐Céline Deau, et al. · British Journal of Haematology · 8
Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy
2010 · Antoine Ittel, Florence Bretelle, et al. · Thrombosis and Haemostasis · 7
Triradial and quadriradial chromosomes detected in a case of B‐cell prolymphocytic leukaemia
2017 · Antoine Ittel, Carine Gervais, et al. · British Journal of Haematology · 6
Four genetic lymphoma-specific events (MYC, BCL2, BCL6 and CCND1) identified in a high grade B lymphoma case
2015 · A Ittel, C Hélias, et al. · Blood Cancer Journal · 6
PDF
Isolated lymphadenopathy inLeishmania infantuminfection: three case reports
2009 · C. Pomares-Estran, G. Cenderello, et al. · Annals of Tropical Medicine and Parasitology · 6
Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features
2019 · Dominique Penther, Pascaline Etancelin, et al. · American Journal of Hematology · 4
PDF
Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group
2018 · Elise Chapiro, Damien Roos-Weil, et al. · Blood · 4
Multiple cytogenetics forms of KMT2A amplification and jumping translocation in a case of myelodysplastic syndrome
2021 · Antoine Ittel, Norbert Vey, et al. · eJHaem · 3
PDF
Molecular combing: A new tool in diagnosing leukemia
2016 · Antoine Ittel, Hélène Zattara, et al. · Cancer Biomarkers · 3
PDF
Venetoclax‐based non‐intensive induction followed by allogenic stem‐cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics
2024 · Amel Soua, Julia Gilhodes, et al. · European Journal Of Haematology · 1
PDF
The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique
2024 · Florence Nguyen‐Khac, Marc Muller, et al. · American Journal of Hematology · 1
PDF
Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients
2023 · Guillaume Berton, Bochra Sedaki, et al. · Blood · 1
PDF
The t(X;5)(q13;q33) Translocation in Myeloid Neoplasms Is Preferentially Associated With Chronic Myelomonocytic Leukemia: A Report From the Groupe Francophone de Cytogénétique Hématologique
2026 · Florence Nguyen‐Khac, Marc Muller, et al. · Genes Chromosomes and Cancer
Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation
2023 · Marine Duranjou, Cécile Castoldi, et al. · Blood
PDF
Efficacy of Chemo-Free Combination Therapy with BRAF Inhibitor and Rituximab in Classic Hairy Cell Leukemia: Insights from the French Experience
2023 · Luca Inchiappa, Lise Willems, et al. · Blood
PDF
P534: Azacitidine Plus Venetoclax for the Treatment of Relapsed and First-line Aml Patients
2022 · S. Garciaz, A.-S. Alary, et al. · HemaSphere
Works count: 37
Citation count: 307
H-index: 8
I10-index: 7
Year
Topic
Type